EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia

Keli Lima iD, Maria Fernanda Lopes Carvalho iD, Diego Antonio Pereira-Martins iD, Frederico Lisboa Nogueira iD, Lívia Bassani Lins de Miranda, Mariane Cristina do Nascimento, Rita de Cássia Cavaglieri, Jan Jacob Schuringa, João Agostinho Machado-Neto iD, Eduardo Magalhães Rego iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242316899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Keli Lima und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematol…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brasil (CAPES).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphatidylinositol-5-phosphate 4-kinase type 2 (PIP4K2) protein family members (PIP4K2A, PIP4K2B, and PIP4K2C) participate in the generation of PIP4,5P2, which acts as a secondary messenger in signal transduction, a substrate for metabolic processes, and has structural functions. In patients with acute myeloid leukemia (AML), high PIP4K2A and PIP4K2C levels are independent markers of a worse prognosis. Recently, our research group reported that THZ-P1-2 (PIP4K2 pan-inhibitor) exhibits anti-leukemic activity by disrupting mitochondrial homeostasis and autophagy in AML models. In the present study, we characterized the expression of PIP4K2 in the myeloid compartment of hematopoietic cells, as well as in AML cell lines and clinical samples with different genetic abnormalities. In ex vivo assays, PIP4K2 expression levels were related to sensitivity and resistance to several antileukemia drugs and highlighted the association between high PIP4K2A levels and resistance to venetoclax. The combination of THZ-P1-2 and venetoclax showed potentiating effects in reducing viability and inducing apoptosis in AML cells. A combined treatment differentially modulated multiple genes, including TAp73, BCL2, MCL1, and BCL2A1. In summary, our study identified the correlation between the expression of PIP4K2 and the response to antineoplastic agents in ex vivo assays in AML and exposed vulnerabilities that may be exploited in combined therapies, which could result in better therapeutic responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteAntineoplastic AgentsHumansCell Line, TumorProto-Oncogene Proteins c-bcl-2Bridged Bicyclo Compounds, HeterocyclicApoptosisPhosphotransferases (Alcohol Group Acceptor)Sulfonamides

Stichwörter der Autor:innen

THZ-P1-2acute myeloid leukemiaphosphatidylinositol-5-phosphate 4-kinase type 2venetoclax

Substanzen

Proto-Oncogene Proteins c-bcl-2Bridged Bicyclo Compounds, HeterocyclicAntineoplastic AgentsPhosphotransferases (Alcohol Group Acceptor)venetoclaxSulfonamidesPIP4K2A protein, human

Autor:innen und Institutionen

  • Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paul…
  • Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo CEP 13566-590, Brazil.
  • Department of Experimental Hematology, University of Groningen, 9718 BG Groningen, The Netherlands.

ORCID-Profile: Keli Lima, Maria Fernanda Lopes Carvalho, Diego Antonio Pereira-Martins, Frederico Lisboa Nogueira, João Agostinho Machado-Neto, Eduardo Magalhães Rego

Förderung

  • São Paulo Research Foundation
  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brasil (CAPES)

Zitieren

APA

Lima, K., Carvalho, M. F. L., Pereira-Martins, D. A., Nogueira, F. L., de Miranda, L. B. L., Nascimento, M. C. D., Cavaglieri, R. C., Schuringa, J. J., Machado-Neto, J. A., & Rego, E. M. (2023). Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242316899

Vancouver

Lima K, Carvalho MFL, Pereira-Martins DA, Nogueira FL, de Miranda LBL, Nascimento MCD, et al. Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242316899

BibTeX
@article{Lima2023,
  author = {Lima, Keli and Carvalho, Maria Fernanda Lopes and Pereira-Martins, Diego Antonio and Nogueira, Frederico Lisboa and de Miranda, Lívia Bassani Lins and Nascimento, Mariane Cristina do and Cavaglieri, Rita de Cássia and Schuringa, Jan Jacob and Machado-Neto, João Agostinho and Rego, Eduardo Magalhães},
  title = {Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242316899}
}
Kostenlos starten →